Tom Hamilton is currently the Co-founder of the CureFA Foundation, a non-profit research group investing in all areas to advance a cure for Friedreich’s Ataxia. Mr Hamilton is also a Director and Executive Committee member of the Friedreich’s Ataxia Research Alliance (FARA). Mr Hamilton also serves on the board of Annaly Capital Management and CFI Inc. Prior to his work in biotech, he was a managing director and strategic advisor to the head of fixed income, currencies and commodities at Barclays Capital in New York. Mr. Hamilton was responsible for the build out of the Global Securitized Products businesses at Barclays along with Municipal Trading and Investment Banking. Prior to Barclays Tom worked at Citigroup Global Markets and began his career at Salomon Brothers, Inc. in New York.
